Compatible with our results, these authors found that the XRCC1 399 Gln/Gln genotype was related to reduced risks of both BCC (OR 0.7; 95% CI 0.4–1.0) and SCC (OR 0.6; 95% CI 0.3–0.9). The gene discussed is XRCC1; the disease is skin basal cell carcinoma.